Advanced Enzyme Technologies Limited

BSE: 540025 NSE: ADVENZYMES
Advanced Enzyme Technologies Limited - chemicals and materials in Thane, Maharashtra, India. FY 2026 financials & compliance.
CIN L24200MH1989PLC051018 Incorporated 15 March 1989 ROC Mumbai HQ Thane, Maharashtra, India
Active Listed - NSE: ADVENZYMES · BSE: 540025 Public Limited Company chemicals and materials
Data last updated
Market Cap
₹3,278 Cr
ADVENZYMES · NSE
Share Price
₹291.15
-0.55% today
Revenue
₹746 Cr
FY 2025-26 · +17.9% YoY
EBITDA
₹225 Cr
Margin 30.2%
Net Profit
₹155 Cr
FY 2025-26 · +18.2% YoY
P/E (TTM)
21.1x
P/B 2.0x
ROE
11.4%
ROCE 15.1%
Debt / Equity
0.02
Interest cover 2.0x

About Advanced Enzyme Technologies Limited

Data last updated: 26 September 2026

Advanced Enzyme Technologies Limited is a public limited company based in Thane, Maharashtra, India. It specialises in industrial enzymes and biochemicals, a part of the broader chemicals and materials sector. Incorporated on 15 March 1989, the company has been in operation for over 37 years.

Registered with ROC Mumbai under CIN L24200MH1989PLC051018. Listed on BSE: 540025 and NSE: ADVENZYMES.

Capital: an authorised share capital of ₹35 Cr and a paid-up capital of ₹22.4 Cr. Formerly known as Advanced Biochemicals Private Limited and Advanced Biochemicals Limited. It is led by directors including Mukund Madhusudan Kabra and Vinodkumar Hiralal Jajoo.

Last AGM: 30 July 2025. Financial statements filed for year ended 31 March 2025. Office: Sun Magnectica 5Th Floor Near Lic Service Road Louis Wadi, Thane, Maharashtra, India – 400604.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹745.76 Cr, a growth of 17.09% compared to the previous year. The net worth stands at ₹1,631.96 Cr (up 14.86% YoY). Total assets are valued at ₹1,720.52 Cr (up 13.95% YoY).

The company has a workforce of approximately 462 employees as per the latest available data. Its group structure includes 3 subsidiaries.

The company is associated with 1 brand - Advanced Enzyme Technologies. As per MCA filings, the company has open charges of ₹30 Cr and satisfied charges of ₹218.5 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website advancedenzymes.com.

Company Details of Advanced Enzyme Technologies Limited
CIN L24200MH1989PLC051018
Registration Number 051018
Incorporation Date 15 March 1989
ROC Mumbai
Listing Status Listed (BSE: 540025, NSE: ADVENZYMES)
Company Status Active
Date of Last AGM 30 July 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Mukund Madhusudan Kabra Whole-Time Director Vinodkumar Hiralal Jajoo Director Rasika Vasant Rathi Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    advancedenzymes.com
  • Social Media
  • Registered Address
    Sun Magnectica 5Th Floor Near Lic Service Road Louis Wadi, Thane, Maharashtra, India – 400604
  • Industry
    Chemicals and Materials, Industrial Enzymes & Biochemicals
Company report
Advanced Enzyme Technologies Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Advanced Enzyme Technologies Limited report

Financials, compliance, directors, charges, ownership and filings for Advanced Enzyme Technologies Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has undergone 2 name changes throughout its history. The company was previously known as Advanced Biochemicals Private Limited, and Advanced Biochemicals Limited. The current legal name is Advanced Enzyme Technologies Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Advanced Enzyme Technologies Limited Current
Advanced Biochemicals Private Limited Previous
Advanced Biochemicals Limited Previous

CIN History of Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has one previous CIN (Corporate Identification Number): U24200MH1989PLC051018. The current CIN is L24200MH1989PLC051018, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24200MH1989PLC051018 Current
U24200MH1989PLC051018 Previous

Associated Brands with Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited operates one associated brand: Advanced Enzyme Technologies. These brands represent Advanced Enzyme Technologies Limited's diversified market presence and brand portfolio.

Brand Description Website
Advanced Enzyme Technologies
Enzymes are manufactured for nutrition, food, feed, and textile industries. advancedenzymes.com

Competitors & Alternatives of Advanced Enzyme Technologies Limited

Brands and companies operating in the same space as Advanced Enzyme Technologies Limited include Zivo Bioscience, Enzymotec, The DuPont Nutrition and Health and 4 more.

Competitor Description Location Founded
Zivo Bioscience Zivo Bioscience Bioactive compounds from algal strain Keego Harbor, United States, United States 1983
Enzymotec Enzymotec Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses. Kfar Saba, Israel, Israel 1998
The DuPont Nutrition and Health The DuPont Nutrition and Health Manufactures a range of health ingredients Copenhagen, Denmark, Denmark 1989
Kaffe Bueno Kaffe Bueno Coffee beans are supplied by Kaffe Bueno in multiple categories. Copenhagen, Denmark, Denmark 2016
Zarbees Zarbees Natural cough remedies and wellness products are developed by Zarbees. Draper, United States, United States 2008
TerraVia TerraVia Algae-based specialty ingredients are manufactured and supplied for food applications. San Francisco, United States, United States 2003
Noblegen Noblegen Naturally-derived ingredients from microorganisms are developed for human nutrition. Peterborough, Canada, Canada 2013

Business Activity of Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Advanced Enzyme Technologies Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited is audited by M S K A & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
M S K A & Associates Locked Locked Locked
Premium access

Complete auditor history for Advanced Enzyme Technologies Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited is currently managed by 9 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Mukund Madhusudan Kabra
Also directs: Saiganesh Enzytech Solutions Private Limited, Advanced Bio-Agro Tech Limited, Advanced Enzytech Solutions Limited and 2 more
Whole-Time Director 04 Sep 1999 27 Years 0 Months Current
Vinodkumar Hiralal Jajoo Director 09 Feb 2019 7 Years 7 Months Current
Rasika Vasant Rathi
Also directs: Scitech Specialities Private Limited
Director 08 Jan 2019 7 Years 8 Months Current
Sunny Sharma
Also directs: Marksans Pharma Limited, Arcatron Mobility Private Limited, Lattice Medtech Private Limited and 5 more
Director 02 Nov 2019 6 Years 10 Months Current
Pramod Kasat
Also directs: Jc Biotech Private Limited, Sai Silks (Kalamandir) Limited, Natural Capsules Limited and 4 more
Director 14 Dec 2016 9 Years 9 Months Current
Vasant Rathi Director 05 Mar 1993 33 Years 6 Months Current
Showing 6 of 9 current directors. View all directors

Financials of Advanced Enzyme Technologies Limited FY 2025-26 filings available

Advanced Enzyme Technologies Limited reported revenue of ₹745.76 Cr (up 17.09% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹746 Cr
+17.1% YoY
EBITDA
₹225 Cr
+15.3% YoY
Profit After Tax
₹155 Cr
+18.2% YoY
Net Worth
₹1,632 Cr
+14.9% YoY
Total Assets
₹1,721 Cr
+13.9% YoY
Total Debt
₹32.01 Cr
-18.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue746637624541529502444
Revenue growth+17.9%+1.9%+11.9%+18.5%+21.3%+12.0%+1.8%
EBITDA225196191153203232203
EBITDA margin+30.2%+30.7%+30.5%+28.4%+38.3%+46.3%+45.8%
Profit before tax233187188140171210179
Net profit155131144109119146129
Net profit margin+20.7%+20.5%+23.1%+20.2%+22.4%+29.0%+29.1%
EPS (₹)15.0711.7211.929.4510.7013.0811.58
Balance sheet
Total assets1,7211,5101,4191,3181,1761,055902
Net worth1,6321,4211,3241,2351,089971840
Total debt32.0139.3547.3133.5034.7422.6327.80
Cash & bank11610812712327419883.02
Net working capital373322325296450336208
Cash flow
Cash from operations157142141140122163141
Cash from investing(71.88)(89.48)(64.80)(286)1.65(27.33)(42.74)
Cash from financing(70.37)(72.54)(59.24)(25.80)(48.50)(26.31)(38.55)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue190203172185186167169146
Revenue growth (YoY)+2.1%+21.7%+1.7%+26.3%+20.3%+5.9%+5.1%-7.4%
Other income13.027.3419.7210.288.858.757.699.62
EBITDA50.9763.2349.3560.0656.4345.6055.2542.42
EBITDA margin+26.9%+31.1%+28.7%+32.5%+30.4%+27.3%+32.7%+29.0%
Depreciation9.8810.1910.2110.089.6210.088.978.90
Interest0.580.570.570.720.760.810.940.93
Profit before tax53.5359.8158.2959.5454.9043.4653.0342.21
Tax14.9414.5515.1114.8114.4616.7314.148.81
Net profit38.5945.2643.1844.7340.4426.7338.8933.40
EPS (₹)3.313.843.793.873.572.373.362.93
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue453351365312273283247
Revenue growth+23.3%+0.5%+18.0%+18.2%+9.5%+7.2%+0.7%
EBITDA10770.9486.4675.0972.8210176.95
EBITDA margin+23.6%+20.2%+23.7%+24.1%+26.7%+35.6%+31.1%
Profit before tax15812113474.2972.0798.4475.85
Net profit13510212356.1353.6270.5257.95
Net profit margin+29.8%+29.1%+33.7%+18.0%+19.7%+24.9%+23.4%
EPS (₹)11.789.159.674.974.886.365.19
Balance sheet
Total assets716633583528483437387
Net worth710629580525480435370
Total debt1.952.761.502.251.580.909.77
Cash & bank2.355.832.0224.7217.981.873.03
Net working capital14815215813712487.0497.54
Cash flow
Cash from operations88.7363.4851.6350.3037.1084.1945.98
Cash from investing(34.19)(1.74)(2.70)(42.35)(14.24)(69.91)(24.94)
Cash from financing(58.25)(57.63)(56.88)(11.99)(10.87)(15.45)(18.56)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11611695.5811612587.2110177.38
Revenue growth (YoY)-7.3%+33.5%-5.2%+49.6%+45.4%-5.6%+10.7%-19.9%
Other income2.295.161.293.0853.854.531.431.66
Total expenses85.4589.5675.9886.1694.5073.0478.8163.85
EBITDA30.4126.8519.6029.5930.5214.1722.0613.53
EBITDA margin+26.2%+23.1%+20.5%+25.6%+24.4%+16.2%+21.9%+17.5%
Depreciation2.923.123.043.002.933.112.892.78
Interest0.040.060.050.050.050.080.060.08
Profit before tax29.7428.8317.8029.6281.3915.5120.5412.33
Tax7.396.554.577.337.414.465.363.20

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 26 Sep 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue190203172185186167169146
Revenue growth (YoY)+2.1%+21.7%+1.7%+26.3%+20.3%+5.9%+5.1%-7.4%
Other income13.027.3419.7210.288.858.757.699.62
EBITDA50.9763.2349.3560.0656.4345.6055.2542.42
EBITDA margin+26.9%+31.1%+28.7%+32.5%+30.4%+27.3%+32.7%+29.0%
Depreciation9.8810.1910.2110.089.6210.088.978.90
Interest0.580.570.570.720.760.810.940.93
Profit before tax53.5359.8158.2959.5454.9043.4653.0342.21
Tax14.9414.5515.1114.8114.4616.7314.148.81
Net profit38.5945.2643.1844.7340.4426.7338.8933.40
EPS (₹)3.313.843.793.873.572.373.362.93
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue746637624541529502444
Revenue growth+17.9%+1.9%+11.9%+18.5%+21.3%+12.0%+1.8%
Other income50.9733.0436.6625.466.428.855.64
Total expenses520441433387327269241
Employee cost16214212811510487.1180.19
EBITDA225196191153203232203
EBITDA margin+30.2%+30.7%+30.5%+28.4%+38.3%+46.3%+45.8%
Depreciation40.0936.5635.2435.0334.9828.4125.78
Interest3.734.634.123.482.962.564.08
Profit before tax233187188140171210179
Tax58.9353.4050.8736.5247.2658.9146.11
Net profit155131144109119146129
Net profit margin+20.7%+20.5%+23.1%+20.2%+22.4%+29.0%+29.1%
EPS (₹)15.0711.7211.929.4510.7013.0811.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital22.3922.3822.3722.3722.3622.3522.34
Reserves & surplus1,6091,3981,3021,2131,066948817
Shareholders' funds (net worth)1,6321,4211,3241,2351,089971840
Minority interest51.1747.8146.9549.1051.7960.1127.80
Secured loans20.5321.5425.1113.2410.7718.3518.48
Unsecured loans11.4817.8122.2020.2623.974.289.32
Total debt32.0139.3547.3133.5034.7422.6327.80
Total liabilities1,7211,5101,4191,3181,1761,055902
Assets
Gross block1,018966902868806753681
Net block692679650649619601563
Capital work in progress51.1721.7141.1021.5015.0710.4210.13
Investments584480403360102121124
Inventories17715714812412193.8880.03
Sundry debtors14511598.5710088.2186.2774.69
Cash & bank balances11610812712327419883.02
Loans & advances21.5219.2332.9314.8819.7316.8214.31
Total current assets460400407363502395252
Total current liabilities86.3777.8181.8766.4452.1758.3643.72
Net working capital373322325296450336208
Total assets1,7211,5101,4191,3181,1761,055902
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash94.2311496.4226719282.6623.06
Net cash from operating activities157142141140122163141
Net cash from investing activities(71.88)(89.48)(64.80)(286)1.65(27.33)(42.74)
Net cash from financing activities(70.37)(72.54)(59.24)(25.80)(48.50)(26.31)(38.55)
Net change in cash14.53(19.53)17.33(171)75.4410959.60
Closing cash11610812712327419883.02
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+17.1%+2.1%+15.4%+2.1%+5.5%+13.0%+5.8%
EBITDA growth+15.3%+2.6%+24.2%-24.3%-12.9%+14.3%+11.0%
PBT growth+24.1%-0.2%+33.8%-17.9%-18.7%+17.4%+10.6%
Net income growth+18.2%-9.2%+32.2%-8.3%-18.5%+12.7%+16.2%
Revenue CAGR (3Y)+11.3%+6.4%+7.5%+6.8%+8.1%+8.7%+10.5%
EBITDA CAGR (3Y)+13.7%-1.2%-6.4%-9.0%+3.4%+12.1%+10.3%
Profitability & leverage
Net income margin+23.3%+21.0%+22.0%+19.2%+23.4%+30.2%+30.0%
Return on capital employed+15.1%+13.6%+14.5%+12.0%+16.4%+22.8%+23.0%
Return on net worth+11.4%+9.8%+10.7%+8.9%+12.0%+16.7%+17.5%
Debt / equity0.020.030.030.030.030.030.04
Long-term debt / equity0.010.020.020.020.020.010.01
Interest cover2.012.912.652.941.771.252.30
Efficiency & per share
Fixed asset turnover0.750.680.700.650.680.700.70
Inventory turnover4.464.174.584.424.935.775.66
Debtors turnover5.735.956.275.736.076.246.66
EPS (₹)15.0711.7211.929.4510.7013.0811.58
Dividend per share (₹)5.355.205.101.001.000.900.60
Book value per share (₹)145.79127.00118.41110.4597.3786.8875.18
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue11611695.5811612587.2110177.38
Revenue growth (YoY)-7.3%+33.5%-5.2%+49.6%+45.4%-5.6%+10.7%-19.9%
Other income2.295.161.293.0853.854.531.431.66
Total expenses85.4589.5675.9886.1694.5073.0478.8163.85
EBITDA30.4126.8519.6029.5930.5214.1722.0613.53
EBITDA margin+26.2%+23.1%+20.5%+25.6%+24.4%+16.2%+21.9%+17.5%
Depreciation2.923.123.043.002.933.112.892.78
Interest0.040.060.050.050.050.080.060.08
Profit before tax29.7428.8317.8029.6281.3915.5120.5412.33
Tax7.396.554.577.337.414.465.363.20
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue453351365312273283247
Revenue growth+23.3%+0.5%+18.0%+18.2%+9.5%+7.2%+0.7%
Other income63.3961.4958.819.819.086.829.00
Total expenses346280279236200183170
Employee cost64.7356.0449.3941.4239.3234.2332.61
EBITDA10770.9486.4675.0972.8210176.95
EBITDA margin+23.6%+20.2%+23.7%+24.1%+26.7%+35.6%+31.1%
Depreciation12.0811.4110.9010.289.568.938.81
Interest0.500.510.390.330.270.221.29
Profit before tax15812113474.2972.0798.4475.85
Tax25.8718.1125.8718.7517.5627.4117.90
Net profit13510212356.1353.6270.5257.95
Net profit margin+29.8%+29.1%+33.7%+18.0%+19.7%+24.9%+23.4%
EPS (₹)11.789.159.674.974.886.365.19
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital22.3922.3822.3722.3722.3622.3522.34
Reserves & surplus687607558503458413348
Shareholders' funds (net worth)710629580525480435370
Secured loans0.000.000.000.010.000.198.07
Unsecured loans1.952.761.502.241.580.711.70
Total debt1.952.761.502.251.580.909.77
Total liabilities716633583528483437387
Assets
Gross block243238213204187173160
Net block151156142143132131127
Capital work in progress48.6920.7521.8611.038.687.349.96
Investments345290256201189184121
Inventories11710196.8876.7980.0863.4259.65
Sundry debtors94.3278.1775.1766.6749.0954.7451.89
Cash & bank balances2.355.832.0224.7217.981.873.03
Loans & advances11.7310.1023.475.3712.867.329.80
Total current assets225196198174160127124
Total current liabilities76.9343.4039.6036.0935.6740.3126.83
Net working capital14815215813712487.0497.54
Total assets716633583528483437387
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash5.601.509.4513.501.512.670.19
Net cash from operating activities88.7363.4851.6350.3037.1084.1945.98
Net cash from investing activities(34.19)(1.74)(2.70)(42.35)(14.24)(69.91)(24.94)
Net cash from financing activities(58.25)(57.63)(56.88)(11.99)(10.87)(15.45)(18.56)
Net change in cash(3.71)4.11(7.95)(4.05)11.99(1.16)2.48
Closing cash2.355.832.0224.7217.981.873.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+28.8%-3.9%+17.3%+14.2%-3.8%+14.6%+11.4%
EBITDA growth+50.6%-18.0%+15.1%+3.1%-27.7%+31.0%+45.5%
PBT growth+30.8%-10.1%+80.4%+3.1%-26.8%+29.8%+60.6%
Net income growth+32.0%-17.0%+119.6%+4.7%-24.0%+21.7%+64.2%
Revenue CAGR (3Y)+13.3%+8.8%+8.8%+8.0%+7.1%+10.2%+12.7%
EBITDA CAGR (3Y)+12.5%-0.9%-5.0%-0.8%+11.3%+26.3%+16.6%
Profitability & leverage
Net income margin+29.1%+29.1%+29.6%+17.8%+20.0%+25.1%+23.4%
Return on capital employed+23.5%+19.9%+27.6%+14.8%+15.7%+23.9%+21.1%
Return on net worth+19.7%+16.9%+22.3%+11.0%+11.9%+17.6%+16.8%
Debt / equity0.000.000.000.000.000.010.04
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover0.530.860.520.510.430.241.89
Efficiency & per share
Fixed asset turnover1.881.561.761.601.521.701.76
Inventory turnover4.153.544.213.973.804.614.18
Debtors turnover5.254.585.155.385.255.325.49
EPS (₹)11.789.159.674.974.886.365.19
Dividend per share (₹)5.355.205.101.001.000.900.60
Book value per share (₹)63.3856.2551.9146.9842.9738.9733.17
Want more history and ratios?
You're viewing the latest exchange-filed financials for Advanced Enzyme Technologies Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Advanced Enzyme Technologies Limited

As per the shareholding pattern for the quarter ended Jun 2026, promoters hold 43.20%, foreign institutional investors hold 26.70%, domestic institutional investors hold 4.80%, retail and other public shareholders hold 25.30% of Advanced Enzyme Technologies Limited.

Promoters: 43.20%DII (Domestic Institutional): 4.80%FII (Foreign Institutional): 26.70%Retail & Others: 25.30%
Jun 2026
QUARTER
43.20% Promoters
4.80% DII (Domestic Institutional)
26.70% FII (Foreign Institutional)
25.30% Retail & Others
Promoter holding - history
Now 43.20% · Jun 2026High 43.30% · Mar 2026Low 43.00% · Dec 2025
42%42.8%43.5%44.3%45%Sep 2025Dec 2025Mar 2026Jun 2026Sep 2025: 43.10%Dec 2025: 43.00%Mar 2026: 43.30%Jun 2026: 43.20%43.30%43.00%43.20%
Shareholding trend - last 6 quarters
Jun 2026Mar 2026Dec 2025Sep 2025
Promoters43.20%43.30%43.00%43.10%
Public56.80%56.70%57.00%56.90%

Group Structure of Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has 3 subsidiary companies. This group structure data is as of FY 2020. The corporate group structure reflects Advanced Enzyme Technologies Limited's business expansion strategy and organizational complexity.

3
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Advanced Bio-Agro Tech Limited U24100MH2004PLC149464 -
Advanced Enzytech Solutions Limited U24200MH2008PLC186383 -
Jc Biotech Private Limited U65993TG1991PTC013624 -

Showing major subsidiaries. Total: 3.

Charges & Borrowings of Advanced Enzyme Technologies Limited

Open charges
₹30 Cr
Satisfied charges
₹218.5 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹15.00 Cr
Citi Bank N.A.₹15.00 Cr
Latest charge details
DateLenderAmountStatus
28 Aug 2006 Hdfc Bank Limited ₹15 Cr Open
22 Jun 2005 Citi Bank N.A. ₹15 Cr Open
29 Jun 2022 Axis Bank Limited ₹5 Cr Satisfied
10 Feb 2022 Others ₹10 Cr Satisfied
25 Mar 2017 Hdfc Bank Limited ₹16.8 Lakh Satisfied

Total charge records: 30 View all charges

Employees and EPFO Compliance at Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited has a workforce of 462 employees as of Mar 28, 2024.

Employee count
462
Active EPFO establishments
1
Employee growth
4.52%
Premium access

Employee and EPFO history for Advanced Enzyme Technologies Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Advanced Enzyme Technologies Limited

Premium access

GST registrations and filing compliance for Advanced Enzyme Technologies Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Advanced Enzyme Technologies Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Advanced Enzyme Technologies Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Advanced Enzyme Technologies Limited

Premium access

MSME payment history for Advanced Enzyme Technologies Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Advanced Enzyme Technologies Limited

Premium access

Corporate group structure for Advanced Enzyme Technologies Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Advanced Enzyme Technologies Limited

Premium access

MCA filings and documents for Advanced Enzyme Technologies Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Advanced Enzyme Technologies Limited

Directors
12 Jun 2026
Pradip Bhailal Shah was appointed as a Additional Director on 12 Jun 2026 & has been associated with this company since 3 months 16 days.
Activity
30 Jul 2025
Advanced Enzyme Technologies Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records.
Activity
31 Mar 2025
Advanced Enzyme Technologies Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
03 Mar 2025
A charge registered on 11 Jun 2013 via Charge ID 10433741 with Dbs Bank Ltd. was fully satisfied on 03 Mar 2025.
Charges
01 Aug 2024
A charge registered on 29 Jun 2022 via Charge ID 100595179 with Axis Bank Limited was fully satisfied on 01 Aug 2024.
Charges
20 Apr 2024
A charge registered on 10 Feb 2022 via Charge ID 100542147 with Others was fully satisfied on 20 Apr 2024.

Recent News on Advanced Enzyme Technologies Limited

Hyundai Motor India added to MSCI Emerging Markets Index
12 Feb 2025 · Thehindubusinessline

Frequently Asked Questions about Advanced Enzyme Technologies Limited

Advanced Enzyme Technologies Limited is an active public limited company in the chemicals and materials sector based in Thane, Maharashtra, India. It was incorporated on 15 March 1989 (37+ years old) and is registered under CIN L24200MH1989PLC051018. Listed on BSE: 540025 and NSE: ADVENZYMES. The company has 462 employees.

Advanced Enzyme Technologies Limited reported revenue of ₹745.76 Cr for FY 2025-26 (up 17.09% YoY) based on consolidated financials.

The current directors of Advanced Enzyme Technologies Limited are:

The primary industry of Advanced Enzyme Technologies Limited is chemicals and materials. The company specifically operates in industrial enzymes and biochemicals. The company is currently active in this sector.

Yes. Advanced Enzyme Technologies Limited is listed on both BSE (code: 540025) and NSE (symbol: ADVENZYMES).

Advanced Enzyme Technologies Limited can be reached at the registered office: Sun Magnectica 5Th Floor Near Lic Service Road Louis Wadi, Thane, Maharashtra, India – 400604, or through the website advancedenzymes.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available